首页 > 最新文献

International journal of ophthalmology最新文献

英文 中文
Anti-inflammatory mechanisms of Hedysarum polybotrys polysaccharide in endotoxin-induced uveitis: insights into candidate genes and pathways. 黑荆多糖在内毒素诱导的葡萄膜炎中的抗炎机制:候选基因和途径的见解。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-02-18 eCollection Date: 2026-01-01 DOI: 10.18240/ijo.2026.02.03
Shuo Yu, Jin-Yi Yu, Xin-Li Liu, Jing Wang, Shi-Lan Feng, Hong Lu

Aim: To identify key genes and inflammatory signaling pathways involved in the anti-inflammatory effects of Hedysarum polybotrys polysaccharide (HPS) in a rat model of endotoxin-induced uveitis (EIU).

Methods: EIU was induced in Wistar rats through subcutaneous injection of lipopolysaccharide (LPS, 200 µg) and the rats were then randomly assigned to EIU group (n=5) and the HPS intervention group (n=5). HPS (400 mg/kg, intraperitoneally) or its carrier was administered 24h and 1h prior to EIU induction. Eyes were examined and enucleated 24h post-induction, and total RNA was extracted from the iris-ciliary body. Gene expression microarrays were used to identify differentially expressed genes (DEGs), followed by bioinformatics analyses, including gene ontology (GO) and pathway analysis. Key findings were not experimentally validated at the mRNA or protein level.

Results: A total of 322 DEGs were identified, comprising 254 mRNA and 68 lncRNA genes. GO analysis revealed significant functional categories, including response to LPS. Pathway analysis identified key signaling pathways involved in uveitis, such as cytokine-cytokine receptor interactions. Notably, 16 mRNA and 7 lncRNA DEGs emerged as central nodes in the gene correlation network.

Conclusion: HPS exerts its anti-inflammatory effects through coordinated signaling pathways, offering insights into potential therapeutic targets for managing uveitis.

目的:在内毒素诱导的葡萄膜炎(EIU)大鼠模型中,探讨红草多糖(HPS)抗炎作用的关键基因和炎症信号通路。方法:采用皮下注射脂多糖(LPS, 200µg)诱导Wistar大鼠发生EIU,随机分为EIU组(n=5)和HPS干预组(n=5)。在EIU诱导前24小时和1小时给药HPS (400 mg/kg,腹腔注射)或其载体。诱导24h后检查眼睛并去核,提取虹膜-睫状体总RNA。基因表达微阵列用于鉴定差异表达基因(DEGs),然后进行生物信息学分析,包括基因本体(GO)和途径分析。关键发现没有在mRNA或蛋白质水平上得到实验验证。结果:共鉴定出322个deg,其中mRNA 254个,lncRNA基因68个。氧化石墨烯分析揭示了重要的功能分类,包括对LPS的反应。途径分析确定了葡萄膜炎的关键信号通路,如细胞因子-细胞因子受体相互作用。值得注意的是,16个mRNA和7个lncRNA deg成为基因相关网络的中心节点。结论:HPS通过协调的信号通路发挥抗炎作用,为葡萄膜炎治疗提供了潜在的治疗靶点。
{"title":"Anti-inflammatory mechanisms of <i>Hedysarum polybotrys</i> polysaccharide in endotoxin-induced uveitis: insights into candidate genes and pathways.","authors":"Shuo Yu, Jin-Yi Yu, Xin-Li Liu, Jing Wang, Shi-Lan Feng, Hong Lu","doi":"10.18240/ijo.2026.02.03","DOIUrl":"10.18240/ijo.2026.02.03","url":null,"abstract":"<p><strong>Aim: </strong>To identify key genes and inflammatory signaling pathways involved in the anti-inflammatory effects of <i>Hedysarum polybotrys</i> polysaccharide (HPS) in a rat model of endotoxin-induced uveitis (EIU).</p><p><strong>Methods: </strong>EIU was induced in Wistar rats through subcutaneous injection of lipopolysaccharide (LPS, 200 µg) and the rats were then randomly assigned to EIU group (<i>n</i>=5) and the HPS intervention group (<i>n</i>=5). HPS (400 mg/kg, intraperitoneally) or its carrier was administered 24h and 1h prior to EIU induction. Eyes were examined and enucleated 24h post-induction, and total RNA was extracted from the iris-ciliary body. Gene expression microarrays were used to identify differentially expressed genes (DEGs), followed by bioinformatics analyses, including gene ontology (GO) and pathway analysis. Key findings were not experimentally validated at the mRNA or protein level.</p><p><strong>Results: </strong>A total of 322 DEGs were identified, comprising 254 mRNA and 68 lncRNA genes. GO analysis revealed significant functional categories, including response to LPS. Pathway analysis identified key signaling pathways involved in uveitis, such as cytokine-cytokine receptor interactions. Notably, 16 mRNA and 7 lncRNA DEGs emerged as central nodes in the gene correlation network.</p><p><strong>Conclusion: </strong>HPS exerts its anti-inflammatory effects through coordinated signaling pathways, offering insights into potential therapeutic targets for managing uveitis.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"19 2","pages":"230-238"},"PeriodicalIF":1.8,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12820618/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146029549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case report and literature review of torpedo maculopathy in four preterm infants. 早产儿鱼雷性黄斑病变4例报告及文献复习。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-02-18 eCollection Date: 2026-01-01 DOI: 10.18240/ijo.2026.02.25
Bo Chen, Hong Yang
{"title":"Case report and literature review of torpedo maculopathy in four preterm infants.","authors":"Bo Chen, Hong Yang","doi":"10.18240/ijo.2026.02.25","DOIUrl":"10.18240/ijo.2026.02.25","url":null,"abstract":"","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"19 2","pages":"414-416"},"PeriodicalIF":1.8,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12820640/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146029629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Off-label intravitreal brolucizumab and bevacizumab for chronic central serous chorioretinopathy. 治疗慢性中枢性浆液性脉络膜视网膜病变的超说明书玻璃体内布卢珠单抗和贝伐单抗。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-02-18 eCollection Date: 2026-01-01 DOI: 10.18240/ijo.2026.02.14
Jung Yeon Joo, Yong Hyun Jun, Seong Taeck Kim

Aim: To compare the intravitreal brolucizumab and bevacizumab injections for chronic central serous chorioretinopathy (cCSC).

Methods: Patients with cCSC were classified into bevacizumab and brolucizumab group. The proportion of complete resolution of subretinal fluid (SRF), best-corrected visual acuity (BCVA), central macular thickness (CMT), and subfoveal choroidal thickness (SFCT) were compared between the two groups.

Results: A total of 40 eyes from 40 patients with aged 34-59y were enrolled in the study. Twenty eyes in bevacizumab group (17 males) and 20 eyes (18 males) in brolucizumab group. Comparing the proportion of complete resolution of SRF, the brolucizumab group was statistically significantly higher than the bevacizumab group (P<0.05). In 1mo, CMT was significantly reduced in the brolucizumab group compared to the bevacizumab group (265±69 vs 319±70 µm; P=0.021). However, there was no significant difference in CMT between the two groups at 2 and 3mo (P>0.05).

Conclusion: Brolucizumab is anatomically and functionally superior to bevacizumab in the treatment of patients with cCSC.

目的:比较玻璃体内注射布卢珠单抗和贝伐单抗治疗慢性中枢性浆液性脉络膜视网膜病变(cCSC)的疗效。方法:将cCSC患者分为贝伐单抗组和勃鲁单抗组。比较两组视网膜下液完全分辨力(SRF)比例、最佳矫正视力(BCVA)、黄斑中央厚度(CMT)、中央窝下脉络膜厚度(SFCT)。结果:40例34-59岁患者共40只眼纳入研究。贝伐单抗组20只眼(男性17只),博鲁单抗组20只眼(男性18只)。比较SRF完全消退比例,勃鲁单抗组显著高于贝伐单抗组(Pvs 319±70µm; P=0.021)。然而,两组在2和3mo时CMT无显著差异(P < 0.05)。结论:Brolucizumab在治疗cCSC患者的解剖学和功能上优于贝伐单抗。
{"title":"Off-label intravitreal brolucizumab and bevacizumab for chronic central serous chorioretinopathy.","authors":"Jung Yeon Joo, Yong Hyun Jun, Seong Taeck Kim","doi":"10.18240/ijo.2026.02.14","DOIUrl":"10.18240/ijo.2026.02.14","url":null,"abstract":"<p><strong>Aim: </strong>To compare the intravitreal brolucizumab and bevacizumab injections for chronic central serous chorioretinopathy (cCSC).</p><p><strong>Methods: </strong>Patients with cCSC were classified into bevacizumab and brolucizumab group. The proportion of complete resolution of subretinal fluid (SRF), best-corrected visual acuity (BCVA), central macular thickness (CMT), and subfoveal choroidal thickness (SFCT) were compared between the two groups.</p><p><strong>Results: </strong>A total of 40 eyes from 40 patients with aged 34-59y were enrolled in the study. Twenty eyes in bevacizumab group (17 males) and 20 eyes (18 males) in brolucizumab group. Comparing the proportion of complete resolution of SRF, the brolucizumab group was statistically significantly higher than the bevacizumab group (<i>P</i><0.05). In 1mo, CMT was significantly reduced in the brolucizumab group compared to the bevacizumab group (265±69 <i>vs</i> 319±70 µm; <i>P</i>=0.021). However, there was no significant difference in CMT between the two groups at 2 and 3mo (<i>P</i>>0.05).</p><p><strong>Conclusion: </strong>Brolucizumab is anatomically and functionally superior to bevacizumab in the treatment of patients with cCSC.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"19 2","pages":"320-325"},"PeriodicalIF":1.8,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12820641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146029658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insights into risk factors and interactive effects on epiretinal membrane development from the National Health and Nutrition Examination Survey. 从全国健康和营养检查调查中了解视网膜前膜发育的危险因素及其相互作用。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-02-18 eCollection Date: 2026-01-01 DOI: 10.18240/ijo.2026.02.20
Xiao-Juan Lai, Mei-Xia Zhang

Aim: To assess risk factors for epiretinal membranes (ERM) and examine their interactions in a nationally representative U.S. dataset.

Methods: Data from the 2005-2008 National Health and Nutrition Examination Survey (NHANES) were analyzed, a nationally representative U.S. dataset. ERM was identified via retinal imaging based on the presence of cellophane changes. Key predictors included age group, eye surgery history, and refractive error, with additional demographic and health-related covariates. Weighted univariate and multiple logistic regression models were used to assess associations and interaction effects between eye surgery and refractive error.

Results: Totally 3925 participants were analyzed. Older age, eye surgery, and refractive errors were significantly associated with ERM. Compared to those under 65y, the odds ratio (OR) for ERM was 3.08 for ages 65-75y (P=0.0014) and 4.76 for ages 75+ years (P=0.0069). Eye surgery increased ERM risk (OR=3.48, P=0.0018). Moderate to high hyperopia and myopia were also associated with ERM (OR=2.65 and 1.80, respectively). A significant interaction between refractive error and eye surgery was observed (P<0.0001). Moderate to high myopia was associated with ERM only in those without eye surgery (OR=1.92, P=0.0443). Eye surgery was most strongly associated with ERM in the emmetropic group (OR=3.60, P=0.0027), followed by the moderate to high myopia group (OR=3.01, P=0.0031).

Conclusion: ERM is significantly associated with aging, eye surgery, and refractive errors. The interaction between eye surgery and refractive error modifies ERM risk and highlights the importance of considering combined effects in clinical risk assessments. These findings may help guide individualized ERM risk assessment that may inform personalized approaches to ERM prevention and management.

目的:评估视网膜前膜(ERM)的危险因素,并在具有全国代表性的美国数据集中检查它们的相互作用。方法:分析2005-2008年全国健康与营养检查调查(NHANES)的数据,这是一个具有全国代表性的美国数据集。通过视网膜成像根据玻璃纸变化的存在来识别ERM。主要预测因素包括年龄组、眼科手术史和屈光不正,以及额外的人口统计学和健康相关协变量。使用加权单变量和多重逻辑回归模型来评估眼科手术与屈光不正之间的关联和相互作用。结果:共分析3925名受试者。年龄、眼部手术和屈光不正与ERM显著相关。与65岁以下患者相比,65-75岁患者ERM的比值比(OR)为3.08 (P=0.0014), 75岁以上患者的比值比(OR)为4.76 (P=0.0069)。眼部手术增加ERM风险(OR=3.48, P=0.0018)。中高远视和近视也与ERM相关(OR分别为2.65和1.80)。屈光不正与眼科手术之间存在显著的相互作用(PP=0.0443)。眼科手术与ERM的相关性在准斜视组最高(OR=3.60, P=0.0027),其次是中高度近视组(OR=3.01, P=0.0031)。结论:ERM与年龄、眼部手术和屈光不正有显著相关性。眼科手术和屈光不正之间的相互作用改变了ERM风险,并强调了在临床风险评估中考虑联合效应的重要性。这些发现可能有助于指导个体化ERM风险评估,从而为ERM预防和管理的个体化方法提供信息。
{"title":"Insights into risk factors and interactive effects on epiretinal membrane development from the National Health and Nutrition Examination Survey.","authors":"Xiao-Juan Lai, Mei-Xia Zhang","doi":"10.18240/ijo.2026.02.20","DOIUrl":"10.18240/ijo.2026.02.20","url":null,"abstract":"<p><strong>Aim: </strong>To assess risk factors for epiretinal membranes (ERM) and examine their interactions in a nationally representative U.S. dataset.</p><p><strong>Methods: </strong>Data from the 2005-2008 National Health and Nutrition Examination Survey (NHANES) were analyzed, a nationally representative U.S. dataset. ERM was identified <i>via</i> retinal imaging based on the presence of cellophane changes. Key predictors included age group, eye surgery history, and refractive error, with additional demographic and health-related covariates. Weighted univariate and multiple logistic regression models were used to assess associations and interaction effects between eye surgery and refractive error.</p><p><strong>Results: </strong>Totally 3925 participants were analyzed. Older age, eye surgery, and refractive errors were significantly associated with ERM. Compared to those under 65y, the odds ratio (OR) for ERM was 3.08 for ages 65-75y (<i>P</i>=0.0014) and 4.76 for ages 75+ years (<i>P</i>=0.0069). Eye surgery increased ERM risk (OR=3.48, <i>P</i>=0.0018). Moderate to high hyperopia and myopia were also associated with ERM (OR=2.65 and 1.80, respectively). A significant interaction between refractive error and eye surgery was observed (<i>P</i><0.0001). Moderate to high myopia was associated with ERM only in those without eye surgery (OR=1.92, <i>P</i>=0.0443). Eye surgery was most strongly associated with ERM in the emmetropic group (OR=3.60, <i>P</i>=0.0027), followed by the moderate to high myopia group (OR=3.01, <i>P</i>=0.0031).</p><p><strong>Conclusion: </strong>ERM is significantly associated with aging, eye surgery, and refractive errors. The interaction between eye surgery and refractive error modifies ERM risk and highlights the importance of considering combined effects in clinical risk assessments. These findings may help guide individualized ERM risk assessment that may inform personalized approaches to ERM prevention and management.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"19 2","pages":"362-369"},"PeriodicalIF":1.8,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12820651/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146029595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Micro/nanoplastics and eye health: a review. 微/纳米塑料与眼睛健康:综述。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-02-18 eCollection Date: 2026-01-01 DOI: 10.18240/ijo.2026.02.24
Lun He, Jiang Zheng, Xiao-Kun Han, Tian-Yu Tao, Jing Zeng, Wei Luo, Xin Chen, Jun-Ming Wang, Xiang-Yin Sha

Micro/nanoplastics (M/NPs) have become pervasive environmental pollutants, posing significant risks to human health through various exposure routes, including ingestion, inhalation, and direct contact. This review systematically examined the potential impacts of M/NPs on ocular health, focusing on exposure pathways, toxicological mechanisms, and resultant damage to the eye. Ocular exposure to M/NPs can occur via direct contact and oral ingestion, with the latter potentially leading to the penetration of particles through ocular biological barriers into ocular tissues. The review highlighted that M/NPs can induce adverse effects on the ocular surface, elevate intraocular pressure, and cause abnormalities in the vitreous and retina. Mechanistically, oxidative stress and inflammation are central to M/NP-induced ocular damage, with smaller particles often exhibiting greater toxicity. Overall, this review underscored the potential risks of M/NPs to ocular health and emphasized the need for further research to elucidate exposure mechanisms, toxicological pathways, and mitigation strategies.

微/纳米塑料已成为普遍存在的环境污染物,通过各种接触途径,包括摄入、吸入和直接接触,对人类健康构成重大风险。本综述系统地研究了M/NPs对眼部健康的潜在影响,重点是暴露途径、毒理学机制和对眼睛的损害。眼部接触M/NPs可通过直接接触和口服摄入发生,后者可能导致颗粒穿透眼部生物屏障进入眼部组织。综述强调,M/NPs可引起眼表不良反应,升高眼压,并引起玻璃体和视网膜异常。从机制上讲,氧化应激和炎症是M/ np引起的眼部损伤的核心,较小的颗粒往往表现出更大的毒性。总体而言,本综述强调了M/NPs对眼部健康的潜在风险,并强调需要进一步研究以阐明暴露机制、毒理学途径和缓解策略。
{"title":"Micro/nanoplastics and eye health: a review.","authors":"Lun He, Jiang Zheng, Xiao-Kun Han, Tian-Yu Tao, Jing Zeng, Wei Luo, Xin Chen, Jun-Ming Wang, Xiang-Yin Sha","doi":"10.18240/ijo.2026.02.24","DOIUrl":"10.18240/ijo.2026.02.24","url":null,"abstract":"<p><p>Micro/nanoplastics (M/NPs) have become pervasive environmental pollutants, posing significant risks to human health through various exposure routes, including ingestion, inhalation, and direct contact. This review systematically examined the potential impacts of M/NPs on ocular health, focusing on exposure pathways, toxicological mechanisms, and resultant damage to the eye. Ocular exposure to M/NPs can occur <i>via</i> direct contact and oral ingestion, with the latter potentially leading to the penetration of particles through ocular biological barriers into ocular tissues. The review highlighted that M/NPs can induce adverse effects on the ocular surface, elevate intraocular pressure, and cause abnormalities in the vitreous and retina. Mechanistically, oxidative stress and inflammation are central to M/NP-induced ocular damage, with smaller particles often exhibiting greater toxicity. Overall, this review underscored the potential risks of M/NPs to ocular health and emphasized the need for further research to elucidate exposure mechanisms, toxicological pathways, and mitigation strategies.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"19 2","pages":"405-413"},"PeriodicalIF":1.8,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12820654/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146029608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ranibizumab on optic disc perfusion in central retinal vein occlusion. 雷尼单抗对视网膜中央静脉闭塞视盘灌注的影响。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-01-18 eCollection Date: 2026-01-01 DOI: 10.18240/ijo.2026.01.10
Xuan Li, Xiao-Feng Hao, Li-Ke Xie, Jin-Hua Luo, Meng-Jiao Zhang

Aim: To evaluate the therapeutic effects of ranibizumab on optic disc and macular microvascular perfusion in central retinal vein occlusion (CRVO) with macular edema (ME).

Methods: Optical coherence tomography angiology (OCTA) parameters, including optic disc vessel density (VD; including whole-disc VD, intra-disc VD, and peripapillary VD), superficial/deep capillary plexus (SCP/DCP) VD, and central macular thickness (CMT) were analyzed. Additional assessments included best-corrected visual acuity (BCVA) via Early Treatment Diabetic Retinopathy Study (ETDRS) chart and hemorheological profiling. CRVO patients received monthly intravitreal ranibizumab injections for three consecutive months. Pre- and post-treatment parameters were statistically compared.

Results: The study comprised 60 CRVO-ME patients (28 males; 32 females), aged 50-78y (mean 63.3±7.6y) and 60 age-/sex-matched healthy controls. As compared with participants exhibiting normal funduscopic findings, CRVO patients demonstrated significantly elevated levels of low-shear-rate whole blood viscosity (LSR-WBV), high-shear-rate whole blood viscosity (HSR-WBV), and aggregation index (AI, all P<0.05). In CRVO-affected eyes, vertical cup-to-disc (C/D) ratio and optic cup volume were significantly smaller, whereas retinal nerve fiber layer (RNFL) thickness was significantly greater, compared to both unaffected contralateral eyes and normal control eyes (all P<0.05). Following treatment, VD of the entire optic disc (P<0.05), intra-disc VD (P<0.05), and peripapillary VD (P<0.05) all increased significantly relative to baseline. CMT decreased significantly (P<0.05), whereas macular SCP-VD and macular DCP-VD showed non-significant slight reductions (P>0.05). At baseline, BCVA of CRVO eyes correlated with whole-disc VD (r=-0.276, P=0.033), intra-disc VD (r=-0.342, P=0.009), and peripapillary VD (r=-0.335, P=0.007), with intra-disc VD demonstrating the strongest association. Besides, BCVA improvement, after the treatment, correlated positively with whole-disc VD (r=0.342, P=0.008) and intra-disc VD (r=0.396, P=0.002).

Conclusion: Optic disc blood perfusion is more closely associated with visual acuity than macular perfusion, suggesting intra-disc VD may serve as a potential biomarker for monitoring visual acuity changes in CRVO. Multiple ranibizumab injections significantly improve optic disc perfusion but may have exerted detrimental effects on the macula. CRVO patients shows higher hemorheological parameters than those with normal fundi. Reduced vertical C/D ratio and optic cup volume may be linked to CRVO incidence, potentially acting as susceptibility factors.

目的:评价雷尼单抗对视网膜中央静脉阻塞(CRVO)合并黄斑水肿(ME)视盘及黄斑微血管灌注的治疗效果。方法:分析光学相干断层扫描血管学(OCTA)参数,包括视盘血管密度(VD,包括全盘VD、盘内VD和乳头周围VD)、浅/深毛细血管丛(SCP/DCP) VD和黄斑中央厚度(CMT)。其他评估包括通过早期治疗糖尿病视网膜病变研究(ETDRS)图表和血液流变学分析获得的最佳矫正视力(BCVA)。CRVO患者连续3个月每月接受雷尼珠单抗玻璃体内注射。对治疗前后参数进行统计学比较。结果:本研究纳入60例CRVO-ME患者(男性28例,女性32例),年龄50-78岁(平均63.3±7.6岁),60例年龄/性别匹配的健康对照。与眼底检查结果正常的受试者相比,CRVO患者低剪切率全血粘度(LSR-WBV)、高剪切率全血粘度(HSR-WBV)和聚集指数(AI,均为PPPPPPP>0.05)水平显著升高。基线时,CRVO眼BCVA与全盘VD (r=-0.276, P=0.033)、盘内VD (r=-0.342, P=0.009)和乳头周围VD (r=-0.335, P=0.007)相关,其中盘内VD相关性最强。治疗后BCVA改善与全盘VD (r=0.342, P=0.008)、盘内VD (r=0.396, P=0.002)呈正相关。结论:视盘血流灌注比黄斑血流灌注与视力的关系更为密切,提示视盘内VD可作为监测CRVO患者视力变化的潜在生物标志物。多次注射雷尼单抗可显著改善视盘灌注,但可能对黄斑产生不利影响。CRVO患者血液流变学指标高于眼底正常患者。垂直C/D比和视杯体积的降低可能与CRVO发生率有关,可能成为敏感性因素。
{"title":"Ranibizumab on optic disc perfusion in central retinal vein occlusion.","authors":"Xuan Li, Xiao-Feng Hao, Li-Ke Xie, Jin-Hua Luo, Meng-Jiao Zhang","doi":"10.18240/ijo.2026.01.10","DOIUrl":"10.18240/ijo.2026.01.10","url":null,"abstract":"<p><strong>Aim: </strong>To evaluate the therapeutic effects of ranibizumab on optic disc and macular microvascular perfusion in central retinal vein occlusion (CRVO) with macular edema (ME).</p><p><strong>Methods: </strong>Optical coherence tomography angiology (OCTA) parameters, including optic disc vessel density (VD; including whole-disc VD, intra-disc VD, and peripapillary VD), superficial/deep capillary plexus (SCP/DCP) VD, and central macular thickness (CMT) were analyzed. Additional assessments included best-corrected visual acuity (BCVA) <i>via</i> Early Treatment Diabetic Retinopathy Study (ETDRS) chart and hemorheological profiling. CRVO patients received monthly intravitreal ranibizumab injections for three consecutive months. Pre- and post-treatment parameters were statistically compared.</p><p><strong>Results: </strong>The study comprised 60 CRVO-ME patients (28 males; 32 females), aged 50-78y (mean 63.3±7.6y) and 60 age-/sex-matched healthy controls. As compared with participants exhibiting normal funduscopic findings, CRVO patients demonstrated significantly elevated levels of low-shear-rate whole blood viscosity (LSR-WBV), high-shear-rate whole blood viscosity (HSR-WBV), and aggregation index (AI, all <i>P</i><0.05). In CRVO-affected eyes, vertical cup-to-disc (C/D) ratio and optic cup volume were significantly smaller, whereas retinal nerve fiber layer (RNFL) thickness was significantly greater, compared to both unaffected contralateral eyes and normal control eyes (all <i>P</i><0.05). Following treatment, VD of the entire optic disc (<i>P</i><0.05), intra-disc VD (<i>P</i><0.05), and peripapillary VD (<i>P</i><0.05) all increased significantly relative to baseline. CMT decreased significantly (<i>P</i><0.05), whereas macular SCP-VD and macular DCP-VD showed non-significant slight reductions (<i>P</i>>0.05). At baseline, BCVA of CRVO eyes correlated with whole-disc VD (<i>r</i>=-0.276, <i>P</i>=0.033), intra-disc VD (<i>r</i>=-0.342, <i>P</i>=0.009), and peripapillary VD (<i>r</i>=-0.335, <i>P</i>=0.007), with intra-disc VD demonstrating the strongest association. Besides, BCVA improvement, after the treatment, correlated positively with whole-disc VD (<i>r</i>=0.342, <i>P</i>=0.008) and intra-disc VD (<i>r</i>=0.396, <i>P</i>=0.002).</p><p><strong>Conclusion: </strong>Optic disc blood perfusion is more closely associated with visual acuity than macular perfusion, suggesting intra-disc VD may serve as a potential biomarker for monitoring visual acuity changes in CRVO. Multiple ranibizumab injections significantly improve optic disc perfusion but may have exerted detrimental effects on the macula. CRVO patients shows higher hemorheological parameters than those with normal fundi. Reduced vertical C/D ratio and optic cup volume may be linked to CRVO incidence, potentially acting as susceptibility factors.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"19 1","pages":"77-82"},"PeriodicalIF":1.8,"publicationDate":"2026-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12782078/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subretinal fluid in rhegmatogenous retinal detachment: potential biomarkers and therapeutic targets for proliferative vitreoretinopathy. 孔源性视网膜脱离的视网膜下液:增殖性玻璃体视网膜病变的潜在生物标志物和治疗靶点。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-01-18 eCollection Date: 2026-01-01 DOI: 10.18240/ijo.2026.01.21
Yi-Shuang Mao, Wei-Hong Yu

Rhegmatogenous retinal detachment (RRD) is a serious ocular condition marked by the separation of the neuroretina from the retinal pigment epithelium (RPE). The pathogenesis of RRD involves intricate molecular and cellular mechanisms, including inflammation, cell migration, and the activation of proliferative signaling pathways. One of the most challenging complications of RRD is proliferative vitreoretinopathy (PVR), which refers to the proliferation and contraction of fibrocellular membranes on the retinal surface and in the vitreous cavity. PVR is a major cause of surgical failure in RRD, as it can lead to recurrent retinal detachment and severe vision loss. However, the pathogenesis of PVR is not yet fully understood, and the treatment options are quite limited. Recent advances in analytical techniques have offered valuable insights into the molecular alterations present in the subretinal fluid (SRF) of patients with RRD. This review seeks to consolidate the current knowledge regarding the SRF profile in RRD and PVR, emphasizing potential biomarkers and therapeutic targets.

孔源性视网膜脱离(RRD)是一种严重的眼部疾病,其特征是神经视网膜与视网膜色素上皮(RPE)分离。RRD的发病机制涉及复杂的分子和细胞机制,包括炎症、细胞迁移和增殖信号通路的激活。RRD最具挑战性的并发症之一是增殖性玻璃体视网膜病变(PVR),这是指视网膜表面和玻璃体腔内纤维细胞膜的增殖和收缩。PVR是RRD手术失败的主要原因,因为它可导致复发性视网膜脱离和严重的视力丧失。然而,PVR的发病机制尚不完全清楚,治疗选择也相当有限。分析技术的最新进展为RRD患者视网膜下液(SRF)中存在的分子改变提供了有价值的见解。本综述旨在巩固目前关于RRD和PVR中SRF概况的知识,强调潜在的生物标志物和治疗靶点。
{"title":"Subretinal fluid in rhegmatogenous retinal detachment: potential biomarkers and therapeutic targets for proliferative vitreoretinopathy.","authors":"Yi-Shuang Mao, Wei-Hong Yu","doi":"10.18240/ijo.2026.01.21","DOIUrl":"10.18240/ijo.2026.01.21","url":null,"abstract":"<p><p>Rhegmatogenous retinal detachment (RRD) is a serious ocular condition marked by the separation of the neuroretina from the retinal pigment epithelium (RPE). The pathogenesis of RRD involves intricate molecular and cellular mechanisms, including inflammation, cell migration, and the activation of proliferative signaling pathways. One of the most challenging complications of RRD is proliferative vitreoretinopathy (PVR), which refers to the proliferation and contraction of fibrocellular membranes on the retinal surface and in the vitreous cavity. PVR is a major cause of surgical failure in RRD, as it can lead to recurrent retinal detachment and severe vision loss. However, the pathogenesis of PVR is not yet fully understood, and the treatment options are quite limited. Recent advances in analytical techniques have offered valuable insights into the molecular alterations present in the subretinal fluid (SRF) of patients with RRD. This review seeks to consolidate the current knowledge regarding the SRF profile in RRD and PVR, emphasizing potential biomarkers and therapeutic targets.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"19 1","pages":"175-180"},"PeriodicalIF":1.8,"publicationDate":"2026-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12782073/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A bibliometric analysis of publication trends in strabismus over the past 30y. 斜视在过去30年出版趋势的文献计量分析。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-01-18 eCollection Date: 2026-01-01 DOI: 10.18240/ijo.2026.01.19
Yi-Han Zhang, Ying Guo, Shu-Jie Zhang, Chen Zhao

Aim: To summarize publication trends in the field of strabismus over the past 30y and predict future research hotspots.

Methods: A total of 2915 English-language articles and reviews on strabismus, published between 1993 and 2022, were retrieved from the Web of Science Core Collection. Bibliometric analyses were performed using VOSviewer and CiteSpace software to explore publication trends, as well as the contributions and collaborative networks of countries/regions, authors, institutions, and journals.

Results: The annual number of publications on strabismus showed a consistent upward trend. The United States (USA) maintained a leading position in this research field while Republic of Korea and China emerged as rapidly advancing contributors over the last decade. The University of California, Los Angeles ranked as the most productive institution, and Jonathan M. Holmes from USA was the most productive author. Journal of AAPOS was the leading journal with the most strabismus publications, whereas the two most highly cited articles were both published in Ophthalmology. Co-occurrence analysis identified pivotal keywords and burst terms, including intermittent exotropia (IXT), acute acquired comitant esotropia (AACE), functional magnetic resonance imaging (fMRI), and surgical treatment, which were confirmed as predominant and frontier topics.

Conclusion: This study provides a comprehensive bibliometric analysis of strabismus research, revealing the evolution of research hotspots over the past 30y and outlining several cutting-edge directions for future investigation.

目的:总结近30年来斜视领域的发表趋势,预测未来的研究热点。方法:从Web of Science Core Collection检索1993 - 2022年间发表的关于斜视的2915篇英文文章和综述。使用VOSviewer和CiteSpace软件进行文献计量分析,以探索出版趋势,以及国家/地区、作者、机构和期刊的贡献和合作网络。结果:斜视相关文献年发表数量呈持续上升趋势。美国在这一研究领域保持领先地位,而大韩民国和中国在过去十年中成为迅速发展的贡献者。加州大学洛杉矶分校被评为最具生产力的机构,来自美国的乔纳森·m·霍姆斯是最具生产力的作家。AAPOS杂志是发表斜视文章最多的主要期刊,而两篇被引最多的文章都发表在Ophthalmology杂志上。共现分析确定了关键关键词和突发术语,包括间歇性外斜视(IXT)、急性获得性共同性内斜视(AACE)、功能磁共振成像(fMRI)和手术治疗,这些被确认为主导和前沿话题。结论:本研究对斜视研究进行了全面的文献计量分析,揭示了近30年来斜视研究热点的演变,并概述了未来研究的几个前沿方向。
{"title":"A bibliometric analysis of publication trends in strabismus over the past 30y.","authors":"Yi-Han Zhang, Ying Guo, Shu-Jie Zhang, Chen Zhao","doi":"10.18240/ijo.2026.01.19","DOIUrl":"10.18240/ijo.2026.01.19","url":null,"abstract":"<p><strong>Aim: </strong>To summarize publication trends in the field of strabismus over the past 30y and predict future research hotspots.</p><p><strong>Methods: </strong>A total of 2915 English-language articles and reviews on strabismus, published between 1993 and 2022, were retrieved from the Web of Science Core Collection. Bibliometric analyses were performed using VOSviewer and CiteSpace software to explore publication trends, as well as the contributions and collaborative networks of countries/regions, authors, institutions, and journals.</p><p><strong>Results: </strong>The annual number of publications on strabismus showed a consistent upward trend. The United States (USA) maintained a leading position in this research field while Republic of Korea and China emerged as rapidly advancing contributors over the last decade. The University of California, Los Angeles ranked as the most productive institution, and Jonathan M. Holmes from USA was the most productive author. <i>Journal of AAPOS</i> was the leading journal with the most strabismus publications, whereas the two most highly cited articles were both published in <i>Ophthalmology</i>. Co-occurrence analysis identified pivotal keywords and burst terms, including intermittent exotropia (IXT), acute acquired comitant esotropia (AACE), functional magnetic resonance imaging (fMRI), and surgical treatment, which were confirmed as predominant and frontier topics.</p><p><strong>Conclusion: </strong>This study provides a comprehensive bibliometric analysis of strabismus research, revealing the evolution of research hotspots over the past 30y and outlining several cutting-edge directions for future investigation.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"19 1","pages":"149-159"},"PeriodicalIF":1.8,"publicationDate":"2026-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12782059/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tocilizumab as an effective treatment option for idiopathic orbital inflammation: a case report and literature review. 托珠单抗作为特发性眼眶炎症的有效治疗选择:一个病例报告和文献综述。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-01-18 eCollection Date: 2026-01-01 DOI: 10.18240/ijo.2026.01.26
Hai-Yang Zhang, Hui-Jie Zhang, Hui-Fang Zhou
{"title":"Tocilizumab as an effective treatment option for idiopathic orbital inflammation: a case report and literature review.","authors":"Hai-Yang Zhang, Hui-Jie Zhang, Hui-Fang Zhou","doi":"10.18240/ijo.2026.01.26","DOIUrl":"10.18240/ijo.2026.01.26","url":null,"abstract":"","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"19 1","pages":"199-201"},"PeriodicalIF":1.8,"publicationDate":"2026-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12782061/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Total score of the computer vision syndrome questionnaire predicts refractive errors and binocular vision anomalies. 计算机视觉综合征问卷总分预测屈光不正和双眼视力异常。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-01-18 eCollection Date: 2026-01-01 DOI: 10.18240/ijo.2026.01.12
Mosaad Alhassan, Tasneem Samman, Hatoun Badukhen, Muhamad Alrashed, Balsam Alabdulkader, Essam Almutleb, Tahani Alqahtani, Ali Almustanyir

Aim: To evaluate the efficacy of the total computer vision syndrome questionnaire (CVS-Q) score as a predictive tool for identifying individuals with symptomatic binocular vision anomalies and refractive errors.

Methods: A total of 141 healthy computer users underwent comprehensive clinical visual function assessments, including evaluations of refractive errors, accommodation (amplitude of accommodation, positive relative accommodation, negative relative accommodation, accommodative accuracy, and accommodative facility), and vergence (phoria, positive and negative fusional vergence, near point of convergence, and vergence facility). Total CVS-Q scores were recorded to explore potential associations between symptom scores and the aforementioned clinical visual function parameters.

Results: The cohort included 54 males (38.3%) with a mean age of 23.9±0.58y and 87 age-matched females (61.7%) with a mean age of 23.9±0.53y. The multiple regression model was statistically significant [R²=0.60, F=13.28, degrees of freedom (DF=17 122, P<0.001]. This indicates that 60% of the variance in total CVS-Q scores (reflecting reported symptoms) could be explained by four clinical measurements: amplitude of accommodation, positive relative accommodation, exophoria at distance and near, and positive fusional vergence at near.

Conclusion: The total CVS-Q score is a valid and reliable tool for predicting the presence of various non-strabismic binocular vision anomalies and refractive errors in symptomatic computer users.

目的:评价计算机视觉综合征总问卷(CVS-Q)评分作为识别症状性双眼视力异常和屈光不正个体的预测工具的有效性。方法:对141名健康计算机用户进行了综合的临床视觉功能评估,包括屈光不正、调节(调节幅度、正相对调节、负相对调节、调节精度和调节设施)和聚光(焦距、正、负融合聚光、近聚光点和聚光设施)的评估。记录CVS-Q总分,以探讨症状评分与上述临床视觉功能参数之间的潜在关联。结果:男性54例(38.3%),平均年龄23.9±0.58岁;女性87例(61.7%),平均年龄23.9±0.53岁。多元回归模型具有统计学意义[R²=0.60,F=13.28,自由度(DF=17 122, p]]结论:CVS-Q总分是预测有症状计算机用户有无各种非斜视双眼视力异常和屈光不正的有效、可靠的工具。
{"title":"Total score of the computer vision syndrome questionnaire predicts refractive errors and binocular vision anomalies.","authors":"Mosaad Alhassan, Tasneem Samman, Hatoun Badukhen, Muhamad Alrashed, Balsam Alabdulkader, Essam Almutleb, Tahani Alqahtani, Ali Almustanyir","doi":"10.18240/ijo.2026.01.12","DOIUrl":"10.18240/ijo.2026.01.12","url":null,"abstract":"<p><strong>Aim: </strong>To evaluate the efficacy of the total computer vision syndrome questionnaire (CVS-Q) score as a predictive tool for identifying individuals with symptomatic binocular vision anomalies and refractive errors.</p><p><strong>Methods: </strong>A total of 141 healthy computer users underwent comprehensive clinical visual function assessments, including evaluations of refractive errors, accommodation (amplitude of accommodation, positive relative accommodation, negative relative accommodation, accommodative accuracy, and accommodative facility), and vergence (phoria, positive and negative fusional vergence, near point of convergence, and vergence facility). Total CVS-Q scores were recorded to explore potential associations between symptom scores and the aforementioned clinical visual function parameters.</p><p><strong>Results: </strong>The cohort included 54 males (38.3%) with a mean age of 23.9±0.58y and 87 age-matched females (61.7%) with a mean age of 23.9±0.53y. The multiple regression model was statistically significant [<i>R</i>²=0.60, <i>F</i>=13.28, degrees of freedom (DF=17 122, <i>P</i><0.001]. This indicates that 60% of the variance in total CVS-Q scores (reflecting reported symptoms) could be explained by four clinical measurements: amplitude of accommodation, positive relative accommodation, exophoria at distance and near, and positive fusional vergence at near.</p><p><strong>Conclusion: </strong>The total CVS-Q score is a valid and reliable tool for predicting the presence of various non-strabismic binocular vision anomalies and refractive errors in symptomatic computer users.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"19 1","pages":"90-96"},"PeriodicalIF":1.8,"publicationDate":"2026-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12782083/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145952013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International journal of ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1